Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features PHAXIAM Therapeutics S.A. Euronext Paris

Equities

PHXM

FR0011471135

Market Closed - Euronext Paris
Other stock markets
 11:35:05 2024-05-17 am EDT 		5-day change 1st Jan Change
3.055 EUR +0.16% Intraday chart for PHAXIAM Therapeutics S.A. +3.56% -33.59%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing... February 21, 2024 at 12:05 pm EST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. PHXM Stock
  5. News PHAXIAM Therapeutics S.A.
  6. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW